Related Articles
Prognostic utility of fluorescence in situ hybridization for determining HER2 gene amplification in breast cancer
Efficacy of lapatinib monotherapy on occult breast cancer presenting with cutaneous metastases: A case report
Therapeutic effect of taxanes on metastatic breast cancer of various immunohistochemical subtypes
Predictive significance of the proportion of ER-positive or PgR-positive tumor cells in response to neoadjuvant chemotherapy for operable HER2-negative breast cancer
mRNA expression of delta-HER2 and its clinicopathological correlation in HER2-overexpressing breast cancer